Item List

Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the acquisition of three cardiology sites from NextStage Clinical Research with Bourne Partners serving as exclusive financial advisor on the transaction. Located across the key market of Texas, they bring experienced research teams, deep connections to community-based provider groups, and a proven track record in cardiovascular research – deepening Iterative Health’s reach into one of the highest-need therapeutic areas.